Cargando…

A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture

Bladder cancer is among the most prevalent cancers worldwide. Currently, few bladder cancer models have undergone thorough characterization to assess their fidelity to patient tumors, especially upon propagation in the laboratory. Here, we establish and molecularly characterize CoCaB 1, an aggressiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Elise Y., Garcia, Jose, Liu, Yuzhen, Vakar-Lopez, Funda, Arora, Sonali, Nguyen, Holly M., Lakely, Bryce, Brown, Lisha, Wong, Alicia, Montgomery, Bruce, Lee, John K., Corey, Eva, Wright, Jonathan L., Hsieh, Andrew C., Lam, Hung-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907272/ https://www.ncbi.nlm.nih.gov/pubmed/33633154 http://dx.doi.org/10.1038/s41598-021-83662-7

Ejemplares similares

Molecular subtyping bladder cancer: Is it ready for clinical practice?
por: VAKAR LOPEZ, Funda
Publicado: (2020)

Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy
por: Ruppender, Nazanin, et al.
Publicado: (2015)

Xenograft and organoid model systems in cancer research
por: Bleijs, Margit, et al.
Publicado: (2019)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Karkampouna, Sofia, et al.
Publicado: (2021)

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
por: Labrecque, Mark P., et al.
Publicado: (2021)

Patient-derived cell line, xenograft and organoid models in lung cancer therapy
por: Huo, Ku-Geng, et al.
Publicado: (2020)

Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer
por: Gendoo, Deena M. A., et al.
Publicado: (2019)

Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
por: Gamboa, Christian Moya, et al.
Publicado: (2021)

Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021)

A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
por: Xu, Xiaoxi, et al.
Publicado: (2023)

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Moro, Massimo, et al.
Publicado: (2017)

Diagnosing 12 prostate needle cores within an hour of biopsy via open-top light-sheet microscopy
por: Xie, Weisi, et al.
Publicado: (2020)

Authentication, characterization and contamination detection of cell lines, xenografts and organoids by barcode deep NGS sequencing
por: Chen, Xiaobo, et al.
Publicado: (2020)

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
por: Guillen, Katrin P., et al.
Publicado: (2022)

Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting
por: Aizawa, Yoshihiro, et al.
Publicado: (2022)

A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
por: Saltsman, James A., et al.
Publicado: (2020)

Reverse AD at Higher Types: Pure, Principled and Denotationally Correct
por: Vákár, Matthijs
Publicado: (2021)

Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas
por: Jakša, Radek, et al.
Publicado: (2022)

Laser capture microdissection enables cellular and molecular studies of tooth root development
por: Sun, Jian-Xun, et al.
Publicado: (2012)

Patient-Derived Xenograft and Organoid Models for Precision Medicine Targeting of the Tumour Microenvironment in Head and Neck Cancer
por: Lee, Tet Woo, et al.
Publicado: (2020)

Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers
por: Pham, Nhu-An, et al.
Publicado: (2021)

Advanced Xenograft Model with Cotransplantation of Patient-Derived Organoids and Endothelial Colony-Forming Cells for Precision Medicine
por: Kwon, Junhye, et al.
Publicado: (2021)

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
por: Van Hemelryk, Annelies, et al.
Publicado: (2022)

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
por: Nguyen, Holly M., et al.
Publicado: (2017)

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases
por: Morrissey, Colm, et al.
Publicado: (2007)

Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation
por: Mathieu, Véronique, et al.
Publicado: (2012)

Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness
por: Zhao, Zhefu, et al.
Publicado: (2017)

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model
por: Mayr, Lisa, et al.
Publicado: (2017)

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Moro, Massimo, et al.
Publicado: (2018)

Increasing aggressiveness of patient-derived xenograft models of cervix carcinoma during serial transplantation
por: Wegner, Catherine S., et al.
Publicado: (2018)

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
por: Golebiewska, Anna, et al.
Publicado: (2020)

Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
por: Tan, Dengxu, et al.
Publicado: (2022)

Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids
por: Van Hemelryk, Annelies, et al.
Publicado: (2023)

New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
por: Rago, Vittoria, et al.
Publicado: (2023)

The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment
por: Bianchi-Frias, Daniella, et al.
Publicado: (2010)

Single-cell derived tumor organoids display diversity in HLA class I peptide presentation
por: Demmers, Laura C., et al.
Publicado: (2020)

RB1-Negative Retinal Organoids Display Proliferation of Cone Photoreceptors and Loss of Retinal Differentiation
por: Kanber, Deniz, et al.
Publicado: (2022)

Veteran-derived cerebral organoids display multifaceted pathological defects in studies on Gulf War Illness
por: Yates, Philip L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8atdva9gdqa03vpte8nbudb1qr